QBiotech received a NMEDD Science and Technology Startup Grant in October that will allow the Rio Rancho company to grow its line of instruments in the life science research and development field.

Founder and CEO Sergey Dryga aims to provide instruments that are intuitive to use, innovative and employ the latest advances in technology. The first instrument, Q Biotech Inceptum is “a first-in-class, chromatography instrument that achieves unparalleled purity  of antibodies or proteins.”

New Mexico Economic Development Department Deputy Secretary Jon Clark announced that QBiotech and three New Mexico companies were awarded Science & Technology Business Startup Grants, each receiving an award of $25,000.

The grants were available to New Mexico-based for-profit science and technology companies with high-growth potential. The grant specifically seeks to support companies that provide a unique product or service, have a clear and compelling business proposition, demonstrate a scalable product and business model, have the potential to create jobs in New Mexico and/or garner private investment and can provide economic benefit to the state greater than the award amount.

“Every year, EDD’s science and technology grants spotlight the cutting-edge innovation and discovery happening right here in New Mexico,” Clark said. “The state is proud to support these companies in their effort to commercialize and grow, and we look forward to continuing to work with them as they expand and create jobs for New Mexicans.”

EDD’s Office of Strategy, Science and Technology  and the Technology Research Collaborative Board reviewed more than 70 applications. Final award recommendations were made to EDD leadership by the TRC Board based on utility of the grant award and the potential for community and economic impact in New Mexico.